Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News MicroVision Inc MVIS

MicroVision, Inc. is a developer and supplier of lidar hardware and software solutions focused on the automotive lidar and advanced driver-assistance systems (ADAS) markets. It is engaged in micro-electromechanical systems (MEMS)-based laser beam scanning technology that integrates MEMS, lasers, optics, hardware, algorithms and machine learning software into its technology to address existing... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:MVIS)

No current opinion is available.

Bullboard Posts (NDAQ:MVIS)

MicroVision Announces $150 Million At-The-Market Equity Faci

BREAKING NEWS: $MVIS MicroVision Announces $150 Million At-The-Market Equity FacilityREDMOND, WA / ACCESSWIRE / March 5, 2024...
whytestocks - March 5, 2024

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Roseene - April 13, 2023

MicroVision ($MVIS) Unveils Images of Newly Integrated MAVIN

<< View Post To Watch Video >>         
GreenStockNews - February 21, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
Roseene - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >>
Roseene - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
Roseene - June 2, 2022